FI83082C - Foerfarande foer framstaellning av cefalosporinantibiotica. - Google Patents

Foerfarande foer framstaellning av cefalosporinantibiotica. Download PDF

Info

Publication number
FI83082C
FI83082C FI850012A FI850012A FI83082C FI 83082 C FI83082 C FI 83082C FI 850012 A FI850012 A FI 850012A FI 850012 A FI850012 A FI 850012A FI 83082 C FI83082 C FI 83082C
Authority
FI
Finland
Prior art keywords
formula
compound
solution
acid
stirred
Prior art date
Application number
FI850012A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI83082B (fi
FI850012L (fi
FI850012A0 (fi
Inventor
Gordon Gad Weingarten
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of FI850012A0 publication Critical patent/FI850012A0/fi
Publication of FI850012L publication Critical patent/FI850012L/fi
Publication of FI83082B publication Critical patent/FI83082B/fi
Application granted granted Critical
Publication of FI83082C publication Critical patent/FI83082C/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/207-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/247-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/26Methylene radicals, substituted by oxygen atoms; Lactones thereof with the 2-carboxyl group
    • C07D501/34Methylene radicals, substituted by oxygen atoms; Lactones thereof with the 2-carboxyl group with the 7-amino radical acylated by carboxylic acids containing hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/235Saturated compounds containing more than one carboxyl group
    • C07C59/305Saturated compounds containing more than one carboxyl group containing ether groups, groups, groups, or groups
    • C07C59/315Saturated compounds containing more than one carboxyl group containing ether groups, groups, groups, or groups containing halogen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FI850012A 1984-01-03 1985-01-02 Foerfarande foer framstaellning av cefalosporinantibiotica. FI83082C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB8400024 1984-01-03
GB848400024A GB8400024D0 (en) 1984-01-03 1984-01-03 Cephalosporin antibiotics

Publications (4)

Publication Number Publication Date
FI850012A0 FI850012A0 (fi) 1985-01-02
FI850012L FI850012L (fi) 1985-07-04
FI83082B FI83082B (fi) 1991-02-15
FI83082C true FI83082C (fi) 1991-05-27

Family

ID=10554497

Family Applications (1)

Application Number Title Priority Date Filing Date
FI850012A FI83082C (fi) 1984-01-03 1985-01-02 Foerfarande foer framstaellning av cefalosporinantibiotica.

Country Status (28)

Country Link
US (1) US4602012A (US06373033-20020416-M00035.png)
JP (1) JPH0791305B2 (US06373033-20020416-M00035.png)
KR (1) KR920001770B1 (US06373033-20020416-M00035.png)
AT (1) AT392279B (US06373033-20020416-M00035.png)
AU (1) AU578441B2 (US06373033-20020416-M00035.png)
BE (1) BE901436A (US06373033-20020416-M00035.png)
CA (1) CA1265512A (US06373033-20020416-M00035.png)
CH (1) CH666274A5 (US06373033-20020416-M00035.png)
DE (1) DE3500090A1 (US06373033-20020416-M00035.png)
DK (1) DK1585A (US06373033-20020416-M00035.png)
ES (2) ES8703884A1 (US06373033-20020416-M00035.png)
FI (1) FI83082C (US06373033-20020416-M00035.png)
FR (1) FR2557571B1 (US06373033-20020416-M00035.png)
GB (2) GB8400024D0 (US06373033-20020416-M00035.png)
GR (1) GR850007B (US06373033-20020416-M00035.png)
HK (1) HK105890A (US06373033-20020416-M00035.png)
HU (1) HU193076B (US06373033-20020416-M00035.png)
IL (1) IL73989A (US06373033-20020416-M00035.png)
IT (1) IT1178349B (US06373033-20020416-M00035.png)
LU (1) LU85719A1 (US06373033-20020416-M00035.png)
NL (1) NL8403974A (US06373033-20020416-M00035.png)
NO (1) NO165400C (US06373033-20020416-M00035.png)
NZ (1) NZ210725A (US06373033-20020416-M00035.png)
PH (1) PH22630A (US06373033-20020416-M00035.png)
PT (1) PT79787B (US06373033-20020416-M00035.png)
SE (2) SE466451B (US06373033-20020416-M00035.png)
SG (1) SG81390G (US06373033-20020416-M00035.png)
ZA (1) ZA8545B (US06373033-20020416-M00035.png)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8320521D0 (en) * 1983-07-29 1983-09-01 Glaxo Group Ltd Chemical process
GB8524001D0 (en) * 1985-09-30 1985-11-06 Glaxo Group Ltd Pharmaceutical composition
DE3804841A1 (de) * 1988-02-17 1989-08-31 Hoechst Ag Cephalosporinderivate und verfahren zu ihrer herstellung
GB8810395D0 (en) * 1988-05-03 1988-06-08 Glaxo Group Ltd Chemical process
GB8810394D0 (en) * 1988-05-03 1988-06-08 Glaxo Group Ltd Chemical process
GB8810396D0 (en) * 1988-05-03 1988-06-08 Glaxo Group Ltd Chemical process
GB8810392D0 (en) * 1988-05-03 1988-06-08 Glaxo Group Ltd Chemical process
GB8810393D0 (en) * 1988-05-03 1988-06-08 Glaxo Group Ltd Chemical process
US5063224A (en) * 1990-07-09 1991-11-05 Eli Lilly And Company R-cefuroxime axetil
DK0508943T3 (da) * 1991-03-11 1995-01-30 Schweizerhall Saeurefab Fremgangsmåde til fremstilling af halogenerede carboxylsyreestere
DK0504107T3 (da) * 1991-03-11 1995-02-13 Schweizerhall Saeurefab Fremgangsmåde til fremstilling af chlorerede carboxylsyreestere
GB9405856D0 (en) * 1994-03-24 1994-05-11 Smithkline Beecham Plc Pharmaceutical formulation
JP2001131071A (ja) * 1999-10-29 2001-05-15 Meiji Seika Kaisha Ltd 非晶質および非晶質を含有する医薬組成物
ES2291433T3 (es) * 2002-03-04 2008-03-01 Orbus Pharma Inc. Composiciones de cefuroxima axetilo de liberacion rapida.
WO2008155615A2 (en) * 2007-06-18 2008-12-24 Orchid Chemicals & Pharmaceuticals Limited An improved process for the preparation of cephalosporin antibiotic

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1453049A (en) * 1973-08-21 1976-10-20 Glaxo Lab Ltd Cephalosporing antibiotics
GB1426717A (en) * 1972-03-13 1976-03-03 Astra Laekemedel Ab Penicillins
GB1425933A (en) * 1972-03-13 1976-02-25 Astra Laekemedel Ab Cephalosporins
GB1571683A (en) * 1976-02-16 1980-07-16 Glaxo Operations Ltd Ester derivatives of cefuroxime
CA1093549A (en) * 1976-02-16 1981-01-13 Michael Gregson Cephalosporin antibiotics
CA1094545A (en) * 1976-02-16 1981-01-27 Michael Gregson Cephalosporin antibiotics
GB1572993A (en) * 1976-02-16 1980-08-13 Glaxo Operations Ltd Ester derivatives of cefuroxime
GB1598568A (en) * 1977-04-19 1981-09-23 Glaxo Lab Ltd Esters of(6r,7r)-3-carbamoyloxymethyl-7-((z)-2-(fur-2-yl)-2-methoxyiminoacetamido)-ceph-3-em-4-carboxylic acid
FR2476087A1 (fr) * 1980-02-18 1981-08-21 Roussel Uclaf Nouvelles oximes derivees de l'acide 3-alkyloxy ou 3-alkyl-thiomethyl 7-amino thiazolyl acetamido cephalosporanique, leur procede de preparation et leur application comme medicaments
IT1210868B (it) * 1982-04-01 1989-09-29 Opos Biochimica Srl Derivati della cefuroxima attivi per via orale procedimenti per laloro preparazione e relative composizioni farmaceutuche.
YU44680B (en) * 1982-07-30 1990-12-31 Glaxo Lab Ltd Process for obtaining very pure amorphous form of cephuroxim axetile
GB8320520D0 (en) * 1983-07-29 1983-09-01 Glaxo Group Ltd Chemical process
GB8320521D0 (en) * 1983-07-29 1983-09-01 Glaxo Group Ltd Chemical process

Also Published As

Publication number Publication date
US4602012A (en) 1986-07-22
HU193076B (en) 1987-08-28
IL73989A (en) 1988-10-31
IT8449383A0 (it) 1984-12-31
NL8403974A (nl) 1985-08-01
GB8500091D0 (en) 1985-02-13
PT79787B (en) 1986-12-11
FI83082B (fi) 1991-02-15
PT79787A (en) 1985-02-01
IT1178349B (it) 1987-09-09
SE8500011L (sv) 1985-07-04
IL73989A0 (en) 1985-04-30
GB2152504B (en) 1987-10-07
CA1265512A (en) 1990-02-06
DE3500090A1 (de) 1985-07-11
NO850010L (no) 1985-07-04
AU3704684A (en) 1985-07-11
PH22630A (en) 1988-10-28
FR2557571A1 (fr) 1985-07-05
JPS60172989A (ja) 1985-09-06
BE901436A (fr) 1985-07-03
AT392279B (de) 1991-02-25
SE8500011D0 (sv) 1985-01-02
DK1585A (da) 1985-07-04
NZ210725A (en) 1988-02-12
ES552577A0 (es) 1987-05-16
HK105890A (en) 1990-12-21
GB8400024D0 (en) 1984-02-08
IT8449383A1 (it) 1986-07-01
SG81390G (en) 1990-11-23
ES539311A0 (es) 1987-03-01
ES8705891A1 (es) 1987-05-16
NO165400B (no) 1990-10-29
FI850012L (fi) 1985-07-04
GB2152504A (en) 1985-08-07
JPH0791305B2 (ja) 1995-10-04
DK1585D0 (da) 1985-01-02
FR2557571B1 (fr) 1987-04-17
CH666274A5 (de) 1988-07-15
ES8703884A1 (es) 1987-03-01
KR920001770B1 (ko) 1992-03-02
DE3500090C2 (US06373033-20020416-M00035.png) 1993-09-23
LU85719A1 (fr) 1985-10-22
KR850005446A (ko) 1985-08-26
ATA1285A (de) 1990-08-15
SE466451B (sv) 1992-02-17
NO165400C (no) 1991-02-06
FI850012A0 (fi) 1985-01-02
HUT37800A (en) 1986-02-28
ZA8545B (en) 1986-09-24
AU578441B2 (en) 1988-10-27
GR850007B (US06373033-20020416-M00035.png) 1985-05-03

Similar Documents

Publication Publication Date Title
FI83082C (fi) Foerfarande foer framstaellning av cefalosporinantibiotica.
FI76093B (fi) Foerfarande foer framstaellning av en amorf form av 1-acetoxietylester av (6r,7r)-3-karbamoyloximetyl-7- /(z)-2-(fur-2-yl)-2-metoxiiminoacetamido/cef-3-em-4-karboxylsyra eller cefuroximaxetil.
FI67384B (fi) Foerfarande foer framstaellning av farmaceutiskt anvaendbara 7-(2-(2-imino-4-tiazolin-4-yl)-2-hydroxiiminoacetamido)-3-cefem-4-karboxylsyraderivat
US4201782A (en) Thiadiazolyl cephalosporin analogs
JP2969283B2 (ja) ピペラジニオセファロスポリン
FI65623C (fi) Foerfarande foer framstaellning av antibiotiskt aktiv (6r 7r)-3-karbamoyloximetyl-7-(2-(fur-2-yl)-2-metoxiiminoacetamido)-cef-3-em-4-karboxylsyra samt dennas icke-giftiga salter
JPS58162592A (ja) セフアロスポリン誘導体およびその製造方法
DK149062B (da) Analogifremgangsmaade til fremstilling af cefuroximestere
EP0002765B1 (de) Cephalosporinderivate, Verfahren zu ihrer Herstellung und pharmazeutische Präparate sowie deren Herstellung
HU184631B (en) Process for preparing cef-3-em-4-carboxylic acid derivatives with antiaiotic activity
JPH0248559B2 (US06373033-20020416-M00035.png)
FI74973B (fi) Foerfarande foer framstaellning av terapeutiskt aktiva 3-/(1-metyl-1-pyrrolidinium)metyl/-3-cefem-4 -karboxylatderivat.
FI63035B (fi) Foerfarande foer framstaellning av 7-alfa-aminoacyl-3-klorcefalosporinderivat
FI62841C (fi) Foerfarande foer framstaellning av terapeutiskt anvaendbara 7-o-aminometyl- eller metylaminometylfenyl- eller cyklohexa dinyl- eller tienylacetamido)-3-(1-karboximetyl- (eller -et yl eller -propyl-)-tetrazol-5-yltiometyl)-3-cefem-4-karboxy lsror samt deras farmaceutiskt godtagbara salter
JPS6289A (ja) アルケンアミドセフアロスポリンエステル
EP0409164B1 (en) Phenacylpyridiniothiocephalosporins
EP0114750A2 (en) Beta-lactam antibacterial agents
US4179502A (en) 7[2-Hydroxyiminoacetamido]cephalosporins
DE2713370C2 (de) 1-Oxadethiacephalosporine, Verfahren zu ihrer Herstellung und Arzneimittel
US4835150A (en) Cephem compounds
EP0084948B1 (en) Penicillin derivatives
US4497811A (en) 1-Oxadethiacephalosporin compound and antibacterial agent containing the _same
US4661480A (en) Formamido oxacephems
EP0098615B1 (en) 1-oxadethiacephalosporin compound and antibacterial agent containing the same
EP0131611A1 (en) $g(b)-LACTAM ANTIBACTERIAL AGENTS

Legal Events

Date Code Title Description
MM Patent lapsed
MM Patent lapsed

Owner name: GLAXO GROUP LIMITED